Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Evolution, Current Landscape, and Future Prospects of Oncolytic Virotherapy in Melanoma: Talimogene Laherparepvec and Beyond.
Journal: Cells
Published: September 16, 2025
Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy.
Journal: Nucleic acid therapeutics
Published: March 12, 2019
Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations.
Journal: BMC cancer
Published: September 27, 2018
A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?
Journal: Expert opinion on biological therapy
Published: February 21, 2018
An Assay that Predicts In Vivo Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis.
Journal: Molecular therapy. Methods & clinical development
Published: December 19, 2017
Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma.
Journal: Oncotarget
Published: September 30, 2017
Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying.
Journal: Gastroenterology
Published: July 04, 2016
Relationships between putative G-quadruplex-forming sequences, RecQ helicases, and transcription.
Journal: BMC medical genetics
Published: January 23, 2015
Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice.
Journal: Nucleic acid therapeutics
Published: December 24, 2014
Last Updated: 09/26/2026